Disease-Modifying Effects of M1 Muscarinic Acetylcholine Receptor Activation in an Alzheimer's Disease Mouse Model.

about

Disease-Modifying Effects of M1 Muscarinic Acetylcholine Receptor Activation in an Alzheimer's Disease Mouse Model.

Item

http://www.wikidata.org/entity/Q48203728

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Disease-Modifying Effects of M ...... zheimer's Disease Mouse Model.

@en

Disease-Modifying Effects of M ...... zheimer's Disease Mouse Model.

@nl

type

Item

label

Disease-Modifying Effects of M ...... zheimer's Disease Mouse Model.

@en

Disease-Modifying Effects of M ...... zheimer's Disease Mouse Model.

@nl

prefLabel

Disease-Modifying Effects of M ...... zheimer's Disease Mouse Model.

@en

Disease-Modifying Effects of M ...... zheimer's Disease Mouse Model.

@nl

P1476

Disease-Modifying Effects of M ...... zheimer's Disease Mouse Model.

@en

P2093

Allan I Levey

http://www.w3.org/2001/XMLSchema#string

David L Brody

http://www.w3.org/2001/XMLSchema#string

Evan P Lebois

http://www.w3.org/2001/XMLSchema#string

J Scott Daniels

http://www.w3.org/2001/XMLSchema#string

Jason P Schroeder

http://www.w3.org/2001/XMLSchema#string

Thomas J Esparza

http://www.w3.org/2001/XMLSchema#string

Thomas M Bridges

http://www.w3.org/2001/XMLSchema#string

P2860

Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders

Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks

Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1

Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

Alzheimer's disease: genes, proteins, and therapy

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory

P304

1177-1187

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACSCHEMNEURO.6B00278

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Craig W. Lindsley

P Jeffrey Conn

P577

2017-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28230352

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

5808561

http://www.w3.org/2001/XMLSchema#string